Combs Andrew
Insider CIK 1825005 · PRLD EVP, Head of Chemistry
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Inc | A Award deriv | 2026-02-04 | 2026-02-05 | 230,000 | — | $0 | 230,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2025-03-25 | 2025-03-27 | 100,000 | $0.69 | $69.0K | 480,123 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-02-04 | 2025-02-05 | 175,000 | — | $0 | 175,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2024-12-23 | 2024-12-26 | 60,000 | $1.37 | $82.2K | 377,623 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2024-12-20 | 2024-12-26 | 3,075 | $1.15 | $3.5K | 317,623 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-03-01 | 2024-03-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-02-07 | 2023-02-09 | 135,000 | — | $0 | 135,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2022-04-01 | 2022-04-04 | 36,062 | — | $0 | 50,397 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2022-03-31 | 2022-04-04 | 36,062 | $1.89 | $68.2K | 304,442 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2021-12-14 | 2021-12-15 | 4,000 | $11.60 | $46.4K | 268,380 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2021-12-13 | 2021-12-15 | 4,000 | $12.12 | $48.5K | 264,380 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-07-20 | 2021-07-22 | 95,000 | — | $0 | 95,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-29 | 2020-09-29 | 1,000 | $19.00 | $19.0K | 260,380 | SEC↗ |